Bristol-Myers Squibb Company (BMY) Stock Chart & Analysis | Market Terminal

Market Terminal®

Market Terminal

Get Full Access To
Market Terminal — Try It For Free

Real-time breakouts. AI-powered analysis. The terminal that levels the playing field.

Open Terminal

BreakoutsScreenerAI AnalysisCalendarsMarketsNewsletters

Market Terminal®

Market Terminal

Get Full Access To
Market Terminal — Try It For Free

Real-time breakouts. AI-powered analysis. The terminal that levels the playing field.

Open Terminal

BreakoutsScreenerAI AnalysisCalendarsMarketsNewsletters

Bristol-Myers Squibb Company operates as a global biopharmaceutical entity, actively involved in the research, development, licensing, production, and worldwide commercialization of its medicinal portfolio. The company's therapeutic areas span hematology, oncology, cardiovascular health, immunology, fibrotic conditions, neuroscience, and infectious diseases like COVID-19. Its significant pharmaceutical offerings include Revlimid, an oral immunomodulatory agent for multiple myeloma, and Eliquis, an oral anticoagulant crucial for reducing stroke risk and systemic embolism in non-valvular atrial fibrillation, as well as treating deep vein thrombosis and pulmonary embolism.

Get Full Access To Market Terminal — Try It For Free

Get Full Access To Market Terminal — Try It For Free

Bristol-Myers Squibb Company (BMY)

Explore More Tools

Get Full Access To
Market Terminal — Try It For Free

Get Full Access To
Market Terminal — Try It For Free